logo
ENTITY
Hutchison China Meditech

Hutchison China Meditech (HCM LN)

26
Analysis
Health Care • Hong Kong
Hutchison China MediTech Limited develops, manufactures, and sells pharmaceutical products. The Company offers drugs for oncology and autoimmune diseases treatment. Hutchison China MediTech markets its products globally.
more
bullish•Hutchison China Meditech
•29 Nov 2019 20:17•Issuer-paid

Hutchison China MediTech - Elunate receives China NRDL inclusion

Hutchison China MediTech (HCM) has announced that Elunate (fruquintinib capsules) have been included in China’s National Reimbursement Drug List...

Logo
Share
bullish•Hutchison China Meditech
•28 Nov 2019 23:59•Issuer-paid

Hutchison China MediTech - Elunate receives China NRDL inclusion

Hutchison China MediTech (HCM) has announced that Elunate (fruquintinib capsules) have been included in China’s National Reimbursement Drug List...

Logo
Share
bullish•Hutchison China Meditech
•10 Oct 2019 19:02•Issuer-paid

Hutchison China MediTech - Surufatinib NETs solid data at ESMO

Hutchison China MediTech (HCM) presented robust SANET-ep Phase III China data at ESMO 2019 on surufatinib in non-pancreatic neuroendocrine tumors...

Logo
Share
bullish•Hutchison China Meditech
•09 Oct 2019 21:34•Issuer-paid

Hutchison China MediTech - Surufatinib NETs solid data at ESMO

Hutchison China MediTech (HCM) presented robust SANET-ep Phase III China data at ESMO 2019 on surufatinib in non-pancreatic neuroendocrine tumours...

Logo
Share
bullish•Hutchison China Meditech
•17 Aug 2018 16:05•Issuer-paid

Hutchison China MediTech - Establishing a global operational presence

Highlights from Hutchison China MediTech’s (HCM) H118 results relate to the substantial pipeline-related newsflow expected in 2018/19, the recent...

Logo
Share

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3

x